Les exosomes - Des transporteurs d’ARN viral qui stimulent l’immunité innée

Sonia Assil; Élodie Décembre; Marlène Dreux

doi:10.1051/medsci/2013291022

Accueil

Tous les numéros

Volume 29 / Numéro 1 (Janvier 2013)

Med Sci (Paris), 29 1 (2013) 104-106

Références

Accès gratuit

Numéro		Med Sci (Paris) Volume 29, Numéro 1, Janvier 2013


Page(s)		104 - 106
Section		Dernières Heures
DOI		https://doi.org/10.1051/medsci/2013291022
Publié en ligne		25 janvier 2013

Howard CR. The biology of hepadnaviruses. J Gen Virol 1986 ; 67 : 1215–1235. [CrossRef] [PubMed] [Google Scholar]
Pijlman GP, Funk A, Kondratieva N, et al. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 2008 ; 4 : 579–591. [CrossRef] [PubMed] [Google Scholar]
Marriott AC, Dimmock NJ. Defective interfering viruses and their potential as antiviral agents. Rev Med Virol 2010 ; 20 : 51–62. [CrossRef] [PubMed] [Google Scholar]
Bartenschlager R, Penin F, Lohmann V, Andre P. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011 ; 19 : 95–103. [CrossRef] [PubMed] [Google Scholar]
Dreux M, Garaigorta U, Boyd B, et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 2012 ; 12 : 558–570. [CrossRef] [PubMed] [Google Scholar]
Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002 ; 2 : 569–579. [PubMed] [Google Scholar]
Reizis B, Bunin A, Ghosh HS, et al. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 2011 ; 29 : 163–183. [CrossRef] [PubMed] [Google Scholar]
Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009 ; 21 : 317–337. [CrossRef] [PubMed] [Google Scholar]
Takahashi K, Asabe S, Wieland S, et al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci USA 2010 ; 107 : 7431–7436. [CrossRef] [Google Scholar]
Florentin J, Aouar B, Dental C, et al. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. Blood 2012 ; 120 : 4544–4551. [CrossRef] [PubMed] [Google Scholar]
Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012 ; 14 : 677–685. [CrossRef] [PubMed] [Google Scholar]
Gerke V, Creutz CE, Moss SE. Annexins: linking Ca²⁺ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005 ; 6 : 449–461. [CrossRef] [PubMed] [Google Scholar]
Mayran N, Parton RG, Gruenberg J. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J 2003 ; 22 : 3242–3253. [CrossRef] [PubMed] [Google Scholar]
Backes P, Quinkert D, Reiss S, et al. Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol 2010 ; 84 : 5775–5789. [CrossRef] [PubMed] [Google Scholar]
Xu Y, Hu Y, Shi B, et al. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 2009 ; 46 : 2640–2646. [CrossRef] [PubMed] [Google Scholar]
Smith DS, Guo K, Barrett BS, et al. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. PLoS Pathog 2011 ; 7 : e1002284. [CrossRef] [PubMed] [Google Scholar]
Decalf J, Fernandes S, Longman R, et al. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med 2007 ; 204 : 2423–2437. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.

[1] Howard CR. The biology of hepadnaviruses. J Gen Virol 1986 ; 67 : 1215–1235. [CrossRef] [PubMed] [Google Scholar]

[2] Pijlman GP, Funk A, Kondratieva N, et al. A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe 2008 ; 4 : 579–591. [CrossRef] [PubMed] [Google Scholar]

[3] Marriott AC, Dimmock NJ. Defective interfering viruses and their potential as antiviral agents. Rev Med Virol 2010 ; 20 : 51–62. [CrossRef] [PubMed] [Google Scholar]

[4] Bartenschlager R, Penin F, Lohmann V, Andre P. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011 ; 19 : 95–103. [CrossRef] [PubMed] [Google Scholar]

[5] Dreux M, Garaigorta U, Boyd B, et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 2012 ; 12 : 558–570. [CrossRef] [PubMed] [Google Scholar]

[6] Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002 ; 2 : 569–579. [PubMed] [Google Scholar]

[7] Reizis B, Bunin A, Ghosh HS, et al. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 2011 ; 29 : 163–183. [CrossRef] [PubMed] [Google Scholar]

[8] Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009 ; 21 : 317–337. [CrossRef] [PubMed] [Google Scholar]

[9] Takahashi K, Asabe S, Wieland S, et al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci USA 2010 ; 107 : 7431–7436. [CrossRef] [Google Scholar]

[10] Florentin J, Aouar B, Dental C, et al. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. Blood 2012 ; 120 : 4544–4551. [CrossRef] [PubMed] [Google Scholar]

[11] Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012 ; 14 : 677–685. [CrossRef] [PubMed] [Google Scholar]

[12] Gerke V, Creutz CE, Moss SE. Annexins: linking Ca²⁺ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005 ; 6 : 449–461. [CrossRef] [PubMed] [Google Scholar]

[13] Mayran N, Parton RG, Gruenberg J. Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells. EMBO J 2003 ; 22 : 3242–3253. [CrossRef] [PubMed] [Google Scholar]

[14] Backes P, Quinkert D, Reiss S, et al. Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol 2010 ; 84 : 5775–5789. [CrossRef] [PubMed] [Google Scholar]

[15] Xu Y, Hu Y, Shi B, et al. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 2009 ; 46 : 2640–2646. [CrossRef] [PubMed] [Google Scholar]

[16] Smith DS, Guo K, Barrett BS, et al. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. PLoS Pathog 2011 ; 7 : e1002284. [CrossRef] [PubMed] [Google Scholar]

[17] Decalf J, Fernandes S, Longman R, et al. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med 2007 ; 204 : 2423–2437. [CrossRef] [PubMed] [Google Scholar]